Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aberrant gene expression associated with recurrent pregnancy loss.

Kwang-Hyun Baek1

  • 1Cell and Gene Therapy Research Institute, Infertility Medical Center, Pochon CHA University, CHA General Hospital, 605 Yeoksam 1-Dong, Kangnam-Gu, Seoul 135-081, Korea. baek@cha.ac.kr

Molecular Human Reproduction
|March 18, 2004
PubMed
Summary

Recurrent pregnancy loss (RPL) is linked to gene expression changes. This review discusses aberrant gene expression in immunity, angiogenesis, and apoptosis, crucial for maintaining normal pregnancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatially resolved quantification of wheat kernel vitreousness using hyperspectral imaging and spectral unmixing.

Frontiers in plant science·2026
Same author

The ubiquitin-proteasome system: A master regulator of cell cycle progression.

Pharmacological research·2026
Same author

The USP19-DnaJC7 Axis Stabilizes p53 in Cisplatin-Treated Epithelial Ovarian Cancer.

Cells·2026
Same author

Key regulatory pathways in recurrent pregnancy loss: Integrating trophoblast dysfunction, angiogenesis, and inflammatory signaling.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Deubiquitinating enzymes in cervical cancer: Molecular mechanisms and therapeutic implications (Review).

International journal of oncology·2026
Same author

Ubiquitin-Specific Protease 49 Interacts with Bax to Modulate Apoptosis.

International journal of molecular sciences·2026

Area of Science:

  • Reproductive biology
  • Genetics
  • Immunology

Background:

  • Recurrent pregnancy loss (RPL) involves chromosomal, immunological, hormonal, and anatomical factors.
  • Maintaining normal pregnancy requires cellular regulation and differential gene expression.
  • Previous studies identified over 30 differentially expressed genes between normal and RPL patients.

Purpose of the Study:

  • To review recent findings on aberrant gene expression in recurrent pregnancy loss.
  • To categorize these genes into immunity-related, angiogenesis-related, and apoptosis-related groups.

Main Methods:

  • Literature review of recent studies on gene expression in RPL.
  • Analysis of gene expression data from normal and RPL patient cohorts.

Related Experiment Videos

Main Results:

  • Aberrant expression of immunity-related genes is implicated in RPL.
  • Changes in angiogenesis-related genes contribute to pregnancy failure.
  • Apoptosis-related gene dysregulation is observed in RPL.

Conclusions:

  • Differential gene expression plays a critical role in recurrent pregnancy loss.
  • Targeting aberrant gene pathways may offer new therapeutic strategies for RPL.